NVCR Q4 2017 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q4 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$54M+77.4% YoY

Gross Profit

$38M70.9% margin

Operating Income

-$5M-8.4% margin

Net Income

-$11M-20.4% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

+7.1%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$5M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$265M

Total Liabilities

$152M

Stockholders' Equity

$114M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$30M	+77.4%
Gross Profit	$38M	$19M	+97.3%
Operating Income	-$5M	-$18M	+74.8%
Net Income	-$11M	-$22M	+50.6%

Geographic Segments

UNITED STATES

$39M72%

E M E A

$15M27%

JAPAN

$80,0000%